ISDS Case Map
medicines
Intellectual property protection for the Swiss pharmaceutical industry has been a key sticking point in negotiations on a free trade agreement with India. Now there seems to be a breakthrough in talks after 16 years. What’s changed?
The clause in the draft free trade agreement text could delay access to affordable, generic versions of patented drugs in India by a minimum of six years, according to documents.
The “TRIPS-Plus” provisions in the India-UK Agreement are a dangerous attempt to increase the power of pharmaceutical companies by placing profits before public health.
MSF and over 50 UK-based civil society organisations and individuals sent this open letter to United Kingdom Prime Minister, urging him to commit that the UK-India Free Trade Agreement will not gut the public health safeguards that are in India’s intellectual property laws.
So what does this trade deal mean for ordinary Africans in a time of deep climate, economic and food crises?
Kenya and Indonesia yesterday signed four bilateral agreements on food security, mining, renewable energy and health following talks between President William Ruto and Indonesia’s Joko Widodo.
The disproportionate intellectual property protections the bloc proposes could threaten the affordability of generics that countries like India and Indonesia export to poorer nations.
Can India protect its development objectives by signing a free trade agreement with an unequal partner with different ambitions?
Groups from India and nearly 40 countries express concern about a leaked chapter from the proposed FTA that they say appears to represent ‘a wish list’ of the pharmaceutical industry.
